vikingtherapeutics.com (VKTX) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Viking Therapeutics (VKTX) metabolik buzilishlar terapiyasi va semizlikka qarshi kurashga e'tibor qaratgan holda, GLP-1 sohasidagi noyob ishlanmalarni monetizatsiya qilishni rejalashtirmoqda. Texnik infratuzilma va shartnomaviy ishlab chiqarish korxonalari klinik sinovlarni kengaytirish uchun to'liq tayyor. Ushbu narxlar grafigi indikator 0.41 darajasida turgan tendentsiyani namoyish etadi. Biznes ulkan talab tufayli yuqori inqirozga chidamlilikka ega, mavsumiylikka bog'liq emas va ventura kapitali oqimiga tayanadi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_VKTX_-_Viking-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "VKTX - Viking Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Viking Therapeutics (VKTX) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Viking Therapeutics|VKTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati vikingtherapeutics.com|VKTX - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Viking Therapeutics, Inc.|VKTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Viking Therapeutics|Oraliq qoplama koeffitsiyenti vikingtherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:Viking Therapeutics
Sifatli aktivlar portfelini diversifikatsiya qilish uchun, emitentning moliyaviy barqarorligini baholash imkonini beruvchi bir yildan ortiq muddatli majburiyatlarning kapitalga nisbatini kuzatish juda muhimdir. Uzoq muddatli qarzlarning kapitalga nisbati tendentsiyasini tahlil qilish orqali, investor Viking Therapeutics (VKTX) metabolik patologiya dori vositalari uchun qimmatbaho klinik sinovlarni qanday moliyalashtirayotganini hamda kredit kapitalini bankrotlikdan himoya qilish bilan qanday muvozanatga keltirayotganini ko'rishi mumkin.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Denali Corp (DNLI)|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati BHVN|Uzoq muddatli qarzning kapitalga nisbati AMLX|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevi Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Medicines PRAX|Uzoq muddatli qarzning kapitalga nisbati Anavex Life Sciences Corp AVXL|CeriBell, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Prothena Corporation PLC PRTA|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ANNX|OMER (Omeros Corp) - Uzoq muddatli qarzning kapitalga nisbati|NGNE - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Neumora Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati SCLX (Scilex Holding)|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACOG (Alpha Cognition)|CGTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati inhibikase.com (IKT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences|ASRT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati vistagen.com (VTGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|ABOS (acumenpharm.com) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alterity Therapeutics|CLNN (clene.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|RLMD (relmada.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|MTVA (metaviatx.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning kapitalga nisbati Passage Bio Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati NERV|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA (Cara Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|MRNS: Uzoq muddatli qarzning kapitalga nisbati|NKGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati